Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Makers Want A Spot In FDA’s New “Network Of Experts”

This article was originally published in The Gray Sheet

Executive Summary

Device industry players argue FDA should expand its vision of the new network-of-experts program to include industry experts who may understand new technologies best. They also raise concerns about confidentiality protection and review delays in public comments to the agency on the new initiative.

Advertisement

Related Content

FDA Expands Network Of Experts After Successful Pilot
CDRH’s Shuren Offers Update On “Network Of Experts” Program
CDRH Launches ‘Innovation Pathway 2.0’ With End-Stage Renal Devices
CDRH Launches ‘Innovation Pathway 2.0’ With End-Stage Renal Devices
MDMA’s Advice To FDA On 510(k) Reform: Tone It Down
CDRH Has New Plan For Tapping Outside Science Experts

Topics

Advertisement
UsernamePublicRestriction

Register

MT030776

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel